RxDoctor Payments Data

Kimberly Polito

Physician Assistant · Brick, NJNPI 1588715296

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.0% of the total across 635 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Amgen at 24.1% of the total. Reporting peaked in 2023 at $2,793 and has fallen 91.2% since, to $247 in 2025. Among physician assistant clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,869in general payments, 2019–2025

Across 635 payments — averaging $13.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • AbbVie$2K
  • Johnson & Johnson$940
  • Pfizer$845
  • AstraZeneca$717
  • Lilly USA, LLC$400
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$8,51296%
  • Education$3574%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,869 in reported general payments places this provider in the 95th percentile of 2,726 physician assistant providers in New Jersey.

See all physician assistant providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
RinvoqUpadacitinib20$148,746
Xeljanz XrTofacitinib Citrate23$132,624
Enbrel SureclickEtanercept17$129,581
Humira(Cf) PenAdalimumab15$115,167
EnbrelEtanercept12$86,445
Hydroxychloroquine Sulfate257$8,177
OxycontinOxycodone Hcl12$6,944
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen240$6,701
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen130$6,173
MethotrexateMethotrexate Sodium136$3,458
Tramadol Hcl266$1,615
Prednisone261$1,400
Colchicine29$1,252
Gabapentin91$932
Leflunomide21$856

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq$1,757$148,74620 claims
AmgenEnbrel$2,139$86,44512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,726 physician assistant providers in New Jersey.

Other physician assistant in Brick

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →